大禹節水(300021.SZ):聯合中標1.11億元寧夏西吉縣馬蓮、將台、夏寨灌區節水灌溉提升改造項目
格隆匯3月21日丨大禹節水(300021.SZ)公佈,2022年3月20日,寧夏回族自治區公共資源交易網發佈《西吉縣馬蓮、將台、夏寨灌區節水灌溉提升改造工程中標結果公吿》,公司全資子公司甘肅大禹節水集團水利水電工程有限責任公司與固原市水利勘測設計院有限公司組成的聯合體中標西吉縣馬蓮、將台、夏寨灌區節水灌溉提升改造項目。
項目總投資規模約1.11億元(工程施工中標費率:以審定最高限價為基準下浮率2.5%;設計中標費率:3.11%);合作模式:EPC+O;項目工期期限:300日曆天;公示期限:2022年3月20日至2022年3月22日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.